Vanguard Fiduciary Trust
SNTI icon

Vanguard Fiduciary Trust’s Senti Biosciences Holdings SNTI Stock Holding History

Vanguard Fiduciary Trust’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Hold
91,193
– – ﹤0.01% 3740
2026
Q1 		$74K Buy
+91,193
New +$88.2K ﹤0.01% 3763

Other funds holding SNTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $357M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Fiduciary Trust's SNTI Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Senti Biosciences Holdings (SNTI) position steady in Q2 2026 at 91,193 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #3740.

Vanguard Fiduciary Trust first reported a position in SNTI in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • Vanguard Fiduciary Trust held 91,193 shares of Senti Biosciences Holdings worth $100K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Senti Biosciences Holdings share count unchanged in Q2 2026.
  • Senti Biosciences Holdings made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3740 holding.
  • Vanguard Fiduciary Trust first reported a position in Senti Biosciences Holdings in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.